Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2019 | Real world data for CLL management

Anthony Mato • 1 Apr 2019
BSH 2019
Chronic Lymphocytic Leukemia

Anthony Mato, MD, MSCE, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the current focus of real world data for chronic lymphocytic leukemia (CLL) management. This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.

More from Anthony Mato

1:42
The importance of genomic testing in CLL prognosis
Anthony Mato • 18 Mar 2022
1:34
Time-limited vs continuous therapy in CLL treatment
Anthony Mato • 18 Mar 2022
2:58
Updates on non-covalent BTK inhibitors and their place in CLL treatment
Anthony Mato • 18 Mar 2022
1:37
Pirtobrutinib resistance in CLL: early findings
Anthony Mato • 18 Mar 2022

Related Videos

3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
3:18
A Phase I study of JBH492, an anti-CCR7 antibody-drug conjugate, in lymphoid malignancies
Pau Abrisqueta • 5 Apr 2024
0:44
Early detection and interception across hematological cancers
Irene Ghobrial • 8 Apr 2024
1:21
Monoclonal B-cell lymphocytosis: a disease to be (or not to be)
Paolo Ghia • 7 Apr 2024
The content of VJHemOnc is intended for healthcare professionals